HIV Drug Therapy Glasgow 2024, Glasgow, Great Britain, 10-13 November 2024
Poster presentation:
- Outcomes after the most common cancers in people with HIV presented by Alisa Timiryasova on behalf of the RESPOND (International Cohort Consortium of Infectious Diseases) and D:A:D (The Data Collection on Adverse Events of Anti-HIV Drugs Study) study groups.POSTER
-
Poster presentation:
Mortality using raltegravir versus other integrase inhibitors in people with HIV in Europe and Australia presented by Erich Tusch on behalf of the RESPOND study group.POSTER
Poster presentation:
Prevalence of HIV drug resistance in people newly diagnosed with HIV who have used pre-exposure prophylaxis in Europe: the PrEPaRE study, presented by Valentina Cambiano on behalf of the RESPOND study group.POSTER
- Changes in the ART coverage and viral suppression from 2020 to 2022 in Kyiv, Ukraine presented by Olga Fursa on behalf of the CARE study group.
Nordic HIV & Virology Conference 2024, Stockholm, Sweden, 25-27 September 2024
Poster presentation:
- RESPONDing to Comtemporary Challenges for Pople Living with HIV: An Evolving Cohort Collaboration presented by Bastian Neesgaard on behalf of RESPOND study group.POSTER
ECCMID 2024, Barcelona, Spain, 27-30 April 2024
Poster presentations:
Conference on Retrovirus and Opportunistic Infections (CROI 2024), Denver, Colorado, USA, 3-6 March 2024
Poster presentations:
- Novel Biomarkers as Determinants of HBsAg Loss in Persons with HIV/HBV on Tenofovir presented by Lorin Begré on behalf of the EuroSIDA Study Group. POSTER
- Temporal Trends of Cardiovascular Disease Incidence in People with HIV from 2001-2021 presented by Nadine Jaschinski on behalf of the RESPOND Study Group. POSTER
- Increased Cancer Risk With Low CD4 Counts Persists Despite Over 2 Years of Virological Suppression presented by Jennifer Hoy on behalf of the RESPOND Study Group. POSTER
IWHOD 2024, Vilamoura, Portugal, 21-23 March 2024
Poster presentations:
- Trends in AIDS-defining illnesses among people living with HIV in Europe: results from the EuroSIDA study (2003-2022) presented by Wendy Bannister on behalf of the EuroSIDA Study Group. POSTER
CROI 2025, San Francisco, USA, 9-12 March 2025
Accepted for poster presentation:
Cancer Incidence in Women With HIV in Europe and Australia: A Combined D:A:D and Respond Analysis will be presented by Win Min Han on behalf of the RESPOND and D:A:D study groups.
Accepted for poster presentation:
Determinants of Steatotic Liver Disease Among People With HIV in Europe and Australia will be presented by Carlotta Riebensahm on behalf of the RESPOND study group.